|
Phenotype (CD27, CD28) of tetramer-positive CD8+ cells in individual groups |
||||||
| Age(yr.) (n = 133) |
0–4 (n = 31) |
5–9 (n = 24) |
10–14 (n = 24) |
15–19 (n = 29) |
20–29 (n = 13) |
60–92 (n = 12) |
|
|
||||||
| % |
||||||
| CD28(-)CD27(+) |
43.2 ± 16.8 |
42.5 ± 14.9 |
39.1 ± 14.4 |
31.3 ± 13.7 |
31.6 ± 11.9 |
17.2 ± 14.1 |
| CD28(+)CD27(+) |
34.9 ± 23.2 |
28.9 ± 14.5 |
26.7 ± 13.4 |
32.8 ± 16.0 |
40.6 ± 14.9 |
28.1 ± 17.2 |
| CD28(-)CD27(-) |
20.8 ± 17.0 |
26.0 ± 18.9 |
30.0 ± 16.9 |
31.4 ± 20.0 |
22.3 ± 12.0 |
40.0 ± 20.5 |
| CD28(+)CD27(-) |
1.1 ± 2.5 |
2.6 ± 3.2 |
4.2 ± 8.7 |
4.5 ± 4.7 |
5.5 ± 6.6 |
22.0 ± 24.2 |
Komatsu et al. Immunity & Ageing 2006 3:11 doi:10.1186/1742-4933-3-11 |
||||||